Fas ligand promotes cell survival of immature human bone marrow CD34+CD38- hematopoietic progenitor cells by suppressing apoptosis

Experimental Hematology

Volumn 27, Issue 9, 1999, Pages 1451-1459

  Josefsen, Dag ^a   Myklebust, June H ^a   Lynch, David H ^b   Stokke, Trond ^a   Blomhoff, Heidi K ^c   Smeland, Erlend B ^a  

^a OSLO UNIVERSITY HOSPITAL   (Norway)

^b AMGEN INC   (United States)

^c UNIVERSITY OF OSLO   (Norway)

Author keywords

Apoptosis; Fas; Fas ligand; Hematopoiesis; Human CD34+CD38 cells

Indexed keywords

CD34 ANTIGEN; CD38 ANTIGEN; DNA FRAGMENT; FAS ANTIGEN; FAS LIGAND; GAMMA INTERFERON; MONOCLONAL ANTIBODY; PROPIDIUM IODIDE; TUMOR NECROSIS FACTOR ALPHA;

APOPTOSIS; ARTICLE; BONE MARROW; CELL SURVIVAL; CONTROLLED STUDY; FLOW CYTOMETRY; HEMATOPOIESIS; HEMATOPOIETIC STEM CELL; HUMAN; HUMAN CELL; PHENOTYPE; PRIORITY JOURNAL;

ADP-RIBOSYL CYCLASE; ADULT; ANTIGENS, CD; ANTIGENS, CD34; ANTIGENS, CD38; ANTIGENS, CD95; ANTIGENS, DIFFERENTIATION; APOPTOSIS; BONE MARROW CELLS; CELL SURVIVAL; FAS LIGAND PROTEIN; HEMATOPOIETIC CELL GROWTH FACTORS; HEMATOPOIETIC STEM CELLS; HUMANS; JURKAT CELLS; MEMBRANE GLYCOPROTEINS; NAD+ NUCLEOSIDASE; PHENOTYPE; RECOMBINANT FUSION PROTEINS;

EID: 0032840760     PISSN: 0301472X     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0301-472X(99)00073-9     Document Type: Article

References (30)

1. Wallach D., Boldin M., Goncharov T., Goltsev Y., Mett I., Malinin N., Adar R., Kovalenko A., Varfolomeev E. Exploring cell death mechanisms by analyzing signaling cascades of the TNF/NGF receptor family. Behring Inst Mitt. 97:1996;144.
2. Itoh N., Yonehara S., Ishii A., Yonehara M., Mizushima S., Sameshima M., Hase A., Seto Y., Nagata S. The polypeptide encoded by the cDNA for human cell surface antigen Fas can mediate apoptosis. Cell. 66:1991;233.
3. Suda T., Takahashi T., Golstein P., Nagata S. Molecular cloning and expression of the Fas ligand, a novel member of the tumor necrosis factor family. Cell. 75:1993;1169.
4. Trauth B.C., Klas C., Peters A.M., Matzku S., Moller P., Falk W., Debatin K.M., Krammer P.H. Monoclonal antibody-mediated tumor regression by induction of apoptosis. Science. 245:1989;301.
5. Yonehara S., Ishii A., Yonehara M. A cell-killing monoclonal antibody (anti-Fas) to a cell surface antigen co-downregulated with the receptor of tumor necrosis factor. J Exp Med. 169:1989;1747.
6. Nagata S., Golstein P. The Fas death factor. Science. 267:1995;1449.
7. Alderson M.R., Armitage R.J., Maraskovsky E., Tough T.W., Roux E., Schooley K., Ramsdell F., Lynch D.H. Fas transduces activation signals in normal human T lymphocytes. J Exp Med. 178:1993;2231.
8. Abreu-Martin M.T., Vidrich A., Lynch D.H., Targan S.R. Divergent induction of apoptosis and IL-8 secretion in HT-29 cells in response to TNF-alpha and ligation of Fas antigen. J Immunol. 155:1995;4147.
9. + human marrow cells is induced by interferon gamma and tumor necrosis factor alpha and potentiates cytokine-mediated hematopoietic suppression in vitro. Blood. 85:1995;3183.
10. Nagafuji K., Shibuya T., Harada M., Mizuno S., Takenaka K., Miyamoto T., Okamura T., Gondo H., Niho Y. Functional expression of Fas antigen (CD95) on hematopoietic progenitor cells. Blood. 86:1995;883.
11. + bone marrow cells. Blood. 84:1994;1473.
12. - progenitor cells. Blood. 77:1991;1218.
13. Barcena A., Park S.W., Banapour B., Muench M.O., Mechetner E. Expression of Fas/CD95 and Bcl-2 by primitive hematopoietic progenitors freshly isolated from human fetal liver. Blood. 88:1996;2013.
14. Smeland E.B., Funderud S., Kvalheim G., Gaudernack G., Rasmussen A.M., Rusten L., Wang M.Y., Tindle R.W., Blomhoff H.K., Egeland T. Isolation and characterization of human hematopoietic progenitor cells. an effective method for positive selection of CD34+ cells Leukemia. 6:1992;845.
15. Nicoletti I., Migliorati G., Pagliacci M.C., Grignani F., Riccardi C. A rapid and simple method for measuring thymocyte apoptosis by propidium iodide staining and flow cytometry. J Immunol Methods. 139:1991;271.
16. Jacobsen F.W., Stokke T., Jacobsen S.E. Transforming growth factor-beta potently inhibits the viability-promoting activity of stem cell factor and other cytokines and induces apoptosis of primitive murine hematopoietic progenitor cells. Blood. 86:1995;2957.
17. Keller J.R., Ortiz M., Ruscetti F.W. Steel factor (c-kit ligand) promotes the survival of hematopoietic stem/progenitor cells in the absence of cell division. Blood. 86:1995;1757.
18. Borge O.J., Ramsfjell V., Veiby O.P., Murphy M.J. Jr., Lok S., Jacobsen S.E. Thrombopoietin, but not erythropoietin promotes viability and inhibits apoptosis of multipotent murine hematopoietic progenitor cells in vitro. Blood. 88:1996;2859.
19. Dhein J., Walczak H., Baumler C., Debatin K.M., Krammer P.H. Autocrine T-cell suicide mediated by APO-1/(Fas/CD95). Nature. 373:1995;438.
20. - bone marrow cells with multilineage potential at the single-cell level. key role of thrombopoietin Blood. 90:1997;2282.
21. Brandt J.E., Bhalla K., Hoffman R. Effects of interleukin-3 and c-kit ligand on the survival of various classes of human hematopoietic progenitor cells. Blood. 83:1994;1507.
22. Katayama N., Clark S.C., Ogawa M. Growth factor requirement for survival in cell-cycle dormancy of primitive murine lymphohematopoietic progenitors. Blood. 81:1993;610.
23. Leary A.G., Zeng H.Q., Clark S.C., Ogawa M. Growth factor requirements for survival in G0 and entry into the cell cycle of primitive human hemopoietic progenitors. Proc Natl Acad Sci U S A. 89:1992;4013.
24. Nagata S. Apoptosis by death factor. Cell. 88:1997;355.
25. Strasser A., O'Connor L. Fas ligand-caught between Scylla and Charybdis. Nat Med. 4:1998;21.
26. Malinin N.L., Boldin M.P., Kovalenko A.V., Wallach D. MAP3K-related kinase involved in NF-kappaB induction by TNF, CD95 and IL-1. Nature. 385:1997;540.
27. - fetal liver cells. Exp Hematol. 27:1999;1428.
28. Tanaka M., Itai T., Adachi M., Nagata S. Downregulation of Fas ligand by shedding. Nat Med. 4:1998;31.
29. Schneider P., Holler N., Bodmer J.L., Hahne M., Frei K., Fontana A., Tschopp J. Conversion of membrane-bound Fas (CD95) ligand to its soluble form is associated with downregulation of its proapoptotic activity and loss of liver toxicity. J Exp Med. 187:1998;1205.
30. Suda T., Hashimoto H., Tanaka M., Ochi T., Nagata S. Membrane Fas ligand kills human peripheral blood T lymphocytes, and soluble Fas ligand blocks the killing. J Exp Med. 186:1997;2045.